Phantom Neuro

Phantom Neuro

Private
Austin, TexasHealthcare & Life Scienceshttps://phantomneuro.com

Last Round

Series A

Apr 15, 2025

Total Funding Raised

$28.26M

Momentum Score

75 /100

Company Overview

Phantom Neuro is a neurotechnology company developing a minimally invasive interface that enables intuitive control of prosthetic limbs and robotic exoskeletons.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Health IoT

Business Model

B2B

Customer Profile

Hardware + Subscription, Government Contracts, Services & Consulting

AI Layer

Application

Keywords

muscle-machine interfaceneural interfaceprosthetic controlminimally invasive implantimplantable sensorbionicsneuroprostheticsrobotic limb controlAI signal processingbrain-computer interfaceBCIimplantable EMGneurotechnologyexoskeleton controlelectromyographyEMGlimb difference technologyFDA Breakthrough Devicehumanoid robot control

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Phantom Neuro Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Phantom Neuro Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series AApr 15, 2025
SeedSep 12, 2022
SeedMar 25, 2022

Phantom Neuro Investors

Notable investors and investment history

InvestorRounds
Risk and ReturnSeries A
Brown AdvisorySeries A
Time BioVenturesSeries A, Seed
Risk and ReturnSeries A
Capital FactorySeed
MainSheet VenturesSeries A
E1 VenturesSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 1, 2025

    Launched a registry connecting amputees with neurointerface trials.

  • Oct 8, 2025

    CEO Connor Glass to present at BioFuture(TM) 2025 conference.

Phantom Neuro Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Phantom Neuro Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Phantom Neuro's valuation, stock price, and market status.

Firmographic Details

HeadquartersAustin, Texas
Employee Range19
Year Founded2020
Last FundingApr 15, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.